Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001209191-22-058607 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-21 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $11.56 | -3,335 | 154.2K | -2% | -$38.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-21 | S | D | 3,335 | $11.56 | 154,213 | D | — | — | (F2) The reporting person acquired 1,032 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022. |